Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go

K Wang, C Wang, H Jiang, Y Zhang, W Lin… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide and is increasing in incidence. Local ablative therapy plays a leading role in HCC …

Decellularized scaffold and its elicited immune response towards the host: the underlying mechanism and means of immunomodulatory modification

J Tan, QY Zhang, LP Huang, K Huang, HQ Xie - Biomaterials Science, 2021 - pubs.rsc.org
The immune response of the host towards a decellularized scaffold is complex. Not only can
a number of immune cells influence this process, but also the characteristics, preparation …

Recent advances in the mechanism research and clinical treatment of anti-angiogenesis in biliary tract cancer

Y Wang, T Chen, K Li, W Mu, Z Liu, A Shi, J Liu… - Frontiers in …, 2021 - frontiersin.org
Biliary tract cancers (BTCs), including cholangiocarcinoma (CCA) and gallbladder cancer
(GC), are malignancies originating from the biliary tract with poor prognosis. In the early …

Irreversible Electroporation Applications

B Partridge, MF Lorenzo, N Dervisis… - … in Veterinary Oncology …, 2021 - Springer
In veterinary medicine, irreversible electroporation (IRE) applications have been evaluated
in several early phase clinical trials evaluating the safety and feasibility of treatment of solid …

Early Detection of Local Tumor Progression after Irreversible Electroporation (IRE) of Hepatocellular Carcinoma Using Gd-EOB-DTPA-Based MR Imaging at 3T

W Bäumler, P Wiggermann, L Lürken, M Dollinger… - Cancers, 2021 - mdpi.com
Simple Summary Liver tumors like hepatocellular carcinoma (HCC) can be treated minimally
invasive, eg, by Irreversible Electroporation (IRE), which destroys the cancer. As it is …